Milican inj. to be listed as medical insurance drug in July

The Ministry of Health and Welfare (MOHW) has announced that Milican inj. of Dongwha Pharm, a new radioactive drug indicated in the treatment of liver cancer, will be listed as medical insurance drug at the ceiling price of 2,409,683 won per injectable set in July 1 following the final license on July last year, together with other drugs including Ostac cap. of Chong Kun Dang Corporation.

Mi...